An abnormality processing system is provided capable of executing appropriate processing in cases where an abnormality occurs in a worker's living body. A management computer 300, if determining that an abnormality is present in a worker's living body, transmits an abnormality signal to an administrator terminal 100, a work device 200, a worker camera 20 and a surveillance camera 50. When receiving the abnormality signal, the administrator terminal 100 displays an image showing that an abnormality has occurred. When receiving the abnormality signal, the work device 200 stops operation. When receiving the abnormality signal, the worker camera 20 and the surveillance camera 50 transmit to the management computer 300 imaging data containing at least data of images before and after a timing at which the abnormality has occurred in the worker's living body.

An Internet of Thing (IoT) sport device includes a body with a processor, a camera and a wireless transceiver coupled to the processor.

Devices are provided that include a faceplate for a medical device. In embodiments, an identifier chip adapted to be affixed to an exterior portion of a faceplate provides a unique identifier for the faceplate. Accordingly, the identifier chip enables tracking and monitoring of an associated medical device. And, in embodiments, the faceplate includes a visual communication alert indicator to enable the faceplate to provide visual cues a user. As such, the status of the medical device and the faceplate can be easily communicated to the user. Methods to use the faceplate are also provided.

The present invention provides an electronic data document (EDD) and related system and method for use in a computerized clinical trial verification system. In an exemplary embodiment, the EDD is authenticated by the creator and validated by the receiver, and comprises an image of a source document (SD) that comprises a masked record of at least one interaction between a clinical trial investigator and a patient enrolled in a clinical trial, at least one revealed portion of the SD that includes evidence relevant to at least one question in a clinical trial questionnaire, and at least one annotation connecting the revealed portion to the at least one question. The present invention provides a computerized system and method for allowing a clinical trial investigator to answer questions from a clinical trial questionnaire pertinent to a clinical trial of a medical treatment using encrypted and partially masked electronic documents comprising images of original patient records. The process of creating and viewing the partially masked electronic documents preferably does not create local copies that can be recalled later.

Systems and methods for predicting exposure to an agent. One or more features are extracted from physiological data. For each respective classifier, (i) the respective classifier is identified, wherein the respective classifier is trained using training data for a respective physiological state, (ii) the respective classifier is applied to the one or more features to obtain a classifier output that represents a likelihood of exposure, (iii) a respective first threshold is applied to the classifier output to determine a patient state classification, and (iv) the patient state classifications are aggregated across a number of time intervals to obtain an aggregate patient state classification for each classifier. The aggregate patient state classifications are combined across the plurality of classifiers to obtain a combined classification, and an indication that the patient has been exposed to the agent is provided when the combined classification exceeds a second threshold.

A method of obtaining and analyzing at least one tissue sample includes forming, in a tissue container, first tracking data associated with the at least one tissue sample. Second tracking data is formed, in a transport container. The second tracking data is associated with the at least one tissue sample. The at least one tissue sample is placed in the tissue container. The first and second tracking data from the tissue container and the transport container are scanned with an electronic scanning system to ensure that the first and second tracking data are both associated with the removed tissue sample.

A remote interactive method, system and computer program product is provided for self-managing a person's regular lifestyle needs through controlled notification and feedback. The invention provides a simple, cost effective and flexible self-management and compliance scheme that does not require third party intervention or treatment options typical with immediate-response or alert-based systems. The invention also provides for long term management and analysis for the benefit of the individual. In implementing the invention in a healthcare environment, the individual will gain a better understanding of managing their lifestyle and behaviour. A related business model is also disclosed.

A system and method for providing automatic setup of a remote patient care environment. Connectivity to a centralized server over a network connection is confirmed. Data reporting for a patient by one or more monitoring devices that are wirelessly connectable is induced through control provided through a user interface. Each of the devices is registered as the device attempts to establish a wireless connection and report the data conditioned on permission for access. Upon granting of the permission for access, the device is wirelessly connected and the data is subsequently received over the wireless connection.

The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for assessing lipid-related health risk, cardiovascular condition, risk of cardiovascular disease, and responsiveness to a therapeutic intervention, which methods utilize lipoprotein size distributions determined by methods of the invention.

A system and method to configure a rule set used in connection with a medical monitoring system for monitoring patients and patient care equipment, especially medication delivery pumps, based on a variety of conditions and parameters associated with monitored biometric information and equipment information and for providing user-defined responses to those conditions and parameters.